What IRulya Therapeutics Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 1 |
| Total trades | 0 | 5 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 14,389 |
| Disposed | 0 | 14,810 |
| Net activity | +0 | −421 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Luca Benatti | Director | Dec 26 | Open-market sale · S | −50,000 | $3.47 | −$174K | 39,179 |
| Thye Dirk | CEO and CMO | Dec 10 | Gift · G | +739,885 | — | — | 739,885 |
| Thye Dirk | CEO and CMO | Dec 10 | Gift · G | −739,885 | — | — | 255,000 |
| Hannah Brendan | CBO, COO & CCO | Dec 05 | Exercise / conversion · M | +25,280 | $0.94 | +$23.8K | 361,827 |
| Hannah Brendan | CBO, COO & CCO | Dec 05 | Exercise / conversion · M | +2,271 | $0.55 | +$1.25K | 336,547 |
| Hannah Brendan | CBO, COO & CCO | Jun 18 | Grant / award · A | +37,736 | $1.20 | +$45.3K | 334,276 |
| Ryan Charles S. | President | Jun 18 | Grant / award · A | +7,548 | $1.20 | +$9.06K | 130,009 |
| Thye Dirk | CEO and CMO | Jun 18 | Grant / award · A | +150,944 | $1.20 | +$181K | 994,885 |
| Luca Benatti | Director | Oct 23 | Other Transaction · J | +8,918 | — | — | 89,179 |
| Thye Dirk | CEO AND CHIEF MEDICAL OFFICER | Aug 30 | Open-market buy · P | +77,000 | $0.70 | +$53.9K | 843,941 |
| Thye Dirk | CEO AND CHIEF MEDICAL OFFICER | Aug 29 | Open-market buy · P | +77,500 | $0.69 | +$53.5K | 766,941 |
| Hannah Brendan | CHIEF BUSINESS OFFICER AND COO | Aug 21 | Open-market buy · P | +23,565 | $0.63 | +$14.8K | 296,540 |
| Hannah Brendan | CHIEF BUSINESS OFFICER AND COO | Aug 21 | Open-market buy · P | +5,000 | $0.62 | +$3.1K | 272,975 |
| Hannah Brendan | CHIEF BUSINESS OFFICER AND COO | Aug 21 | Open-market buy · P | +2,280 | $0.61 | +$1.39K | 267,975 |
| Hannah Brendan | CHIEF BUSINESS OFFICER AND COO | Aug 20 | Open-market buy · P | +3,424 | $0.60 | +$2.05K | 265,695 |
| Hannah Brendan | CHIEF BUSINESS OFFICER AND COO | Aug 20 | Open-market buy · P | +2,500 | $0.61 | +$1.53K | 262,271 |
| Ryan Charles S. | PRESIDENT | Aug 20 | Open-market buy · P | +48,387 | $0.65 | +$31.5K | 122,461 |
| Hannah Brendan | CHIEF BUSINESS OFFICER AND COO | Aug 19 | Open-market buy · P | +2,155 | $0.58 | +$1.25K | 259,771 |
| Hannah Brendan | CHIEF BUSINESS OFFICER AND COO | Jun 04 | Exercise / conversion · M | +56,061 | $0.55 | +$30.8K | 257,616 |
| Thye Dirk | CHIEF EXECUTIVE OFFICER | Jan 16 | Exercise / conversion · M | +149,999 | $0.94 | +$141K | 689,441 |
Loading...